ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and advanced software solutions in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+ and Delta4Phantom+MR; Delta4 HexaMotion; and Delta4Insight, Delta4DVH Anatomy, Delta4 Machine QA, and Delta4 Statistics Module for the quality assurance in advanced radiation therapy techniques, including VMAT, RapidArc, IMRT, and tomotherapy. It also provides installation services, service agreements, and additional services. It sells its products through sales offices and distributors. ScandiDos AB (publ) was founded in 2001 and is headquartered in Uppsala, Sweden.…
Affärsvärlden Scandidos analys aktieråd är aktien köpvärd?
ScandiDos (STO: SDOS) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 25 employees.
The shares were at 0.4080 SEK on 20 November 2026, down 62.6% over 52 weeks. Its 52-week range is 0.3980 SEK to 1.315 SEK: the price is 69.0% below the high and 2.5% above the low.
Its market capitalisation is 29.08M SEK.
ScandiDos reports return on equity of -8.2%, an operating margin of -15.5% and revenue down 46.2% year over year.
It holds more cash than debt, a net cash position of 13.68M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.